Post Exposure Prophylaxis News and Research

RSS

Nanoviricide drug candidate effectiveness confirmed against rabies and influenzas

NanoViricides, Inc. has said that in a confirmatory study, their nanoviricide drug candidates exhibited a consistent 20% to 30% survival in the test animals.

13 Nov 2007

Tamiflu could halve the pandemic influenza death toll versus no intervention

Treatment with the oral antiviral Tamiflu (oseltamivir) and prophylaxis for people exposed to infected patients could be one of the most cost-effective strategies for reducing illness and death during an influenza pandemic.

23 Jun 2007

WHO tackles rabies, snake bites and scorpion stings

Although more than 12 million people each year are bitten by dogs or snakes, or stung by scorpions, the world's capacity to treat them is inadequate.

9 Jan 2007

New plan to confront HIV-related health worker shortages

Launch of a coordinated global plan to address a major and often overlooked barrier to preventing and treating HIV/AIDS: the severe shortage of health workers, particularly in developing nations.

15 Aug 2006

British man had to cheat to access to HIV treatment

'Robert' says a therapy known as PEP, post-exposure prophylaxis, is not widely available and has not been well publicised and he is seeking a judicial review of government policy.

23 Feb 2006

New federal guidelines for the use of antiretroviral drugs to prevent HIV infection

The Centers for Disease Control and Prevention (CDC) today announced new federal guidelines for the use of antiretroviral drugs to prevent HIV infection after exposure to HIV through sexual intercourse, sexual assault, injection drug use, or accidents.

20 Jan 2005